Literature DB >> 27406604

Impact of New Technologies and Approaches for Post-Myocardial Infarction Ventricular Tachycardia Ablation During Long-Term Follow-Up.

Seigo Yamashita1, Hubert Cochet2, Frédéric Sacher2, Saagar Mahida2, Benjamin Berte2, Darren Hooks2, Jean-Marc Sellal2, Nora Al Jefairi2, Antonio Frontera2, Yuki Komatsu2, Han S Lim2, Sana Amraoui2, Arnaud Denis2, Nicolas Derval2, Maxime Sermesant2, François Laurent2, Mélèze Hocini2, Michel Haïssaguerre2, Michel Montaudon2, Pierre Jaïs2.   

Abstract

BACKGROUND: During the past years, many innovations have been introduced to facilitate catheter ablation of post-myocardial infarction ventricular tachycardia. However, the predictors of outcome after ablation were not thoroughly studied. METHODS AND
RESULTS: From 2009 to 2013, consecutive patients referred for post-myocardial infarction ventricular tachycardia ablation were included. The end point of the procedure was complete elimination of local abnormal ventricular activities (LAVA) and ventricular tachycardia (VT) noninducibility. The predictors of outcome with primary end point of VT recurrence were assessed. A total of 125 patients were included (age: 64±11 years; 7 women) for 142 procedures. The left ventricle was accessed via transseptal, retrograde aortic, and epicardial approaches in 87%, 33%, and 37% of patients, respectively. Three-dimensional electroanatomical mapping system was used in 70%, multipolar catheter in 51%, and real-time image integration in 38% (from magnetic resonance imaging in 39% and multidetector computed tomography in 93%) of patients. Before ablation, VT was inducible in 75%, and endocardial/epicardial LAVA were present in 88%/75%. After ablation, complete LAVA elimination was achieved in 60%, and VT noninducibility in 83%. During a median follow-up of 850 days (interquartile range, 439-1707), VT recurrence was observed in 36%. Multivariable analysis identified 3 independent outcome predictors: the ability to achieve complete LAVA elimination (R(2)=0.29; P<0.0001; risk ratio=0.52 [0.38-0.70]), the use of real-time image integration (R(2)=0.21; P=0.0006; risk ratio=0.49 [0.33-0.74]), and the use of multipolar catheters (R(2)=0.08; P=0.05; risk ratio=0.75 [0.56-1.00]).
CONCLUSIONS: Achievement of complete LAVA elimination and use of scar integration from imaging and multipolar catheters to focus high-density mapping are independent predictors of VT-free survival after catheter ablation for post-myocardial infarction ventricular tachycardia.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  catheter ablation; heart failure; infarction; myocardial infarction; ventricular tachycardia

Mesh:

Year:  2016        PMID: 27406604     DOI: 10.1161/CIRCEP.116.003901

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  20 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

2.  Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial (PAUSE-SCD): rationale and study design.

Authors:  Minglong Chen; Shulin Wu; Yan Yao; Jian Jiang; Chenyang Jiang; Yumei Xue; Xianzhang Zhan; Hongde Hu; Guosheng Fu; Kai Gu; Hailei Liu; Ligang Ding; Ruhong Jiang; Fa-Po Chung; Yenn-Jiang Lin; Yuichi Hori; Yuki Komatsu; Akiko Ueda; Kyoko Soejima; Young Hoon Kim; Akihiko Nogami; Shiro Nakahara; Shih-Ann Chen; Roderick Tung
Journal:  J Interv Card Electrophysiol       Date:  2019-03-19       Impact factor: 1.900

Review 3.  [3-D mapping and ablation of recurrent ventricular tachycardia in patients with ischemic cardiomyopathy].

Authors:  Kristina Wasmer; Lars Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-05-22

4.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

5.  Point-by-point versus multisite electrode mapping in VT ablation: does freedom from VT recurrences depend on mapping catheter? An observational study.

Authors:  Petra Maagh; Arnd Christoph; Markus Sebastian Müller; Henning Dopp; Gunnar Plehn; Axel Meissner
Journal:  J Interv Card Electrophysiol       Date:  2018-01-22       Impact factor: 1.900

6.  A systematic review and meta-analysis comparing radiofrequency catheter ablation with medical therapy for ventricular tachycardia in patients with ischemic and non-ischemic cardiomyopathies.

Authors:  Venkatesh Ravi; Abhushan Poudyal; Smriti Khanal; Charl Khalil; Aviral Vij; David Sanders; Timothy Larsen; Richard G Trohman; Tolga Aksu; Roderick Tung; Pasquale Santangeli; Jeffrey Winterfield; Parikshit S Sharma; Henry D Huang
Journal:  J Interv Card Electrophysiol       Date:  2022-06-27       Impact factor: 1.900

7.  Limitations and Challenges in Mapping Ventricular Tachycardia: New Technologies and Future Directions.

Authors:  Adam J Graham; Michele Orini; Pier D Lambiase
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-08

8.  High-Density Mapping in Ventricular Tachycardia Ablation: A PentaRay® Study.

Authors:  Petra Maagh; Arnd Christoph; Henning Dopp; Markus Sebastian Mueller; Gunnar Plehn; Axel Meissner
Journal:  Cardiol Res       Date:  2017-12-22

Review 9.  Optimal Ablation Techniques for Ventricular Tachycardia Management.

Authors:  Jose M Sanchez; Chen Yuan; Henry H Hsia
Journal:  J Innov Card Rhythm Manag       Date:  2018-01-15

Review 10.  Substrate Mapping and Ablation for Ventricular Tachycardia in Patients with Structural Heart Disease: How to Identify Ventricular Tachycardia Substrate.

Authors:  Takeshi Kitamura; Claire A Martin; Konstantinos Vlachos; Ruairidh Martin; Antonio Frontera; Masateru Takigawa; Nathaniel Thompson; Ghassen Cheniti; Gregoire Massouille; Anna Lam; Felix Bourier; Josselin Duchateau; Thomas Pambrun; Arnaud Denis; Nicolas Derval; Meleze Hocini; Michel HaÏssaguerre; Hubert Cochet; Pierre JaÏs; Frédéric Sacher
Journal:  J Innov Card Rhythm Manag       Date:  2019-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.